메뉴 건너뛰기




Volumn 82, Issue 6, 2012, Pages 591-593

Valuing gene testing in children with possible neurofibromatosis 1

Author keywords

British Columbia; Economic value; Genetic testing; Neurofibromatosis 1

Indexed keywords

ARTICLE; BONE DYSPLASIA; CHILD; CLINICAL DECISION MAKING; GENETIC SCREENING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; NEUROFIBROMATOSIS; OPHTHALMOLOGY; OPTIC NERVE GLIOMA; PRIORITY JOURNAL; QUALITY OF LIFE; SCOLIOSIS;

EID: 84869094686     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2011.01801.x     Document Type: Article
Times cited : (5)

References (13)
  • 1
    • 77952786822 scopus 로고    scopus 로고
    • Genomic medicine - an updated primer.
    • Feero WG, Guttmacher AE, Collins FS. Genomic medicine - an updated primer. N Engl J Med 2011: 362 (21): 2001-2011.
    • (2011) N Engl J Med , vol.362 , Issue.21 , pp. 2001-2011
    • Feero, W.G.1    Guttmacher, A.E.2    Collins, F.S.3
  • 2
    • 40949132576 scopus 로고    scopus 로고
    • Health supervision for children with neurofibromatosis.
    • Hersh JH. Health supervision for children with neurofibromatosis. Pediatrics 2008: 121 (3): 633-642.
    • (2008) Pediatrics , vol.121 , Issue.3 , pp. 633-642
    • Hersh, J.H.1
  • 3
    • 0025186923 scopus 로고
    • Neurofibromatosis-1: a maximum likelihood estimation of mutation rate.
    • Clementi M, Barbujani G, Turolla L, Tenconi R. Neurofibromatosis-1: a maximum likelihood estimation of mutation rate. Hum Genet 1990: 84 (2): 116-118.
    • (1990) Hum Genet , vol.84 , Issue.2 , pp. 116-118
    • Clementi, M.1    Barbujani, G.2    Turolla, L.3    Tenconi, R.4
  • 4
    • 0030957310 scopus 로고    scopus 로고
    • The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.
    • Gutmann DH, Aylsworth A, Carey JC et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997: 278 (1): 51-57.
    • (1997) JAMA , vol.278 , Issue.1 , pp. 51-57
    • Gutmann, D.H.1    Aylsworth, A.2    Carey, J.C.3
  • 5
    • 0034094731 scopus 로고    scopus 로고
    • Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.
    • DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 2000: 105(3 Pt 1): 608-614.
    • (2000) Pediatrics , vol.105 , Issue.3 PART 1 , pp. 608-614
    • DeBella, K.1    Szudek, J.2    Friedman, J.M.3
  • 6
    • 0034081412 scopus 로고    scopus 로고
    • Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.
    • Messiaen LM, Callens T, Mortier G et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000: 15 (6): 541-555.
    • (2000) Hum Mutat , vol.15 , Issue.6 , pp. 541-555
    • Messiaen, L.M.1    Callens, T.2    Mortier, G.3
  • 7
    • 84870505201 scopus 로고    scopus 로고
    • University of Alabama at Birmingham. Medical Genetics Laboratory, from. Accessed on May 1, 2011.
    • University of Alabama at Birmingham. Medical Genetics Laboratory 2008, from http://medicine.uab.edu/genetics/82633/medgenomics/. Accessed on May 1, 2011.
    • (2008)
  • 8
    • 0027395630 scopus 로고
    • National neurofibromatosis foundation international database.
    • Friedman JM, Birch P, Greene C. National neurofibromatosis foundation international database. Am J Med Genet 1993: 45 (1): 88-91.
    • (1993) Am J Med Genet , vol.45 , Issue.1 , pp. 88-91
    • Friedman, J.M.1    Birch, P.2    Greene, C.3
  • 9
    • 34147172816 scopus 로고    scopus 로고
    • Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.
    • Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 2007: 61 (3): 189-198.
    • (2007) Ann Neurol , vol.61 , Issue.3 , pp. 189-198
    • Listernick, R.1    Ferner, R.E.2    Liu, G.T.3    Gutmann, D.H.4
  • 10
    • 17644388078 scopus 로고    scopus 로고
    • Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)?
    • Alwan S, Tredwell SJ, Friedman JM. Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)? Clin Genet 2005: 67 (5): 378-390.
    • (2005) Clin Genet , vol.67 , Issue.5 , pp. 378-390
    • Alwan, S.1    Tredwell, S.J.2    Friedman, J.M.3
  • 11
    • 84870551504 scopus 로고    scopus 로고
    • British Columbia Ministry of Health. Medical Services Commission Payment Schedule, from. Accessed on May 1, 2011
    • British Columbia Ministry of Health. Medical Services Commission Payment Schedule 2011, from http://www.health.gov.bc.ca/msp/infoprac/physbilling/payschedule/index.html. Accessed on May 1, 2011.
    • (2011)
  • 12
    • 66549119634 scopus 로고    scopus 로고
    • Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children.
    • Regier DA, Friedman JM, Makela N, Ryan M, Marra CA. Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children. Clin Genet 2009: 75 (6): 514-521.
    • (2009) Clin Genet , vol.75 , Issue.6 , pp. 514-521
    • Regier, D.A.1    Friedman, J.M.2    Makela, N.3    Ryan, M.4    Marra, C.A.5
  • 13
    • 70349498475 scopus 로고    scopus 로고
    • Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options.
    • Elefteriou F, Kolanczyk M, Schindeler A et al. Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options. Am J Med Genet A 2009: 149A (10): 2327-2338.
    • (2009) Am J Med Genet A , vol.149 A , Issue.10 , pp. 2327-2338
    • Elefteriou, F.1    Kolanczyk, M.2    Schindeler, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.